- Home
- PRME vs MBI Comparison
PRME vs MBI Comparison
Compare PRME & MBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- MBI
- Stock Information
- Founded
- PRME 2019
- MBI 1973
- Country
- PRME United States
- MBI United States
- Employees
- PRME N/A
- MBI N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- MBI Property-Casualty Insurers
- Sector
- PRME Health Care
- MBI Finance
- Exchange
- PRME Nasdaq
- MBI Nasdaq
- Market Cap
- PRME 191.7M
- MBI 222.1M
- IPO Year
- PRME 2022
- MBI 1987
- Fundamental
- Price
- PRME $4.21
- MBI $4.95
- Analyst Decision
- PRME Buy
- MBI Buy
- Analyst Count
- PRME 6
- MBI 2
- Target Price
- PRME $9.38
- MBI $6.25
- AVG Volume (30 Days)
- PRME 5.8M
- MBI 205.5K
- Earning Date
- PRME 08-08-2025
- MBI 08-05-2025
- Dividend Yield
- PRME N/A
- MBI N/A
- EPS Growth
- PRME N/A
- MBI N/A
- EPS
- PRME N/A
- MBI N/A
- Revenue
- PRME $3,846,000.00
- MBI $37,000,000.00
- Revenue This Year
- PRME $104.12
- MBI N/A
- Revenue Next Year
- PRME $108.24
- MBI N/A
- P/E Ratio
- PRME N/A
- MBI N/A
- Revenue Growth
- PRME 550.76
- MBI 285.71
- 52 Week Low
- PRME $1.11
- MBI $3.22
- 52 Week High
- PRME $5.95
- MBI $7.46
- Technical
- Relative Strength Index (RSI)
- PRME 60.42
- MBI 64.85
- Support Level
- PRME $3.71
- MBI $4.87
- Resistance Level
- PRME $5.15
- MBI $5.15
- Average True Range (ATR)
- PRME 0.53
- MBI 0.17
- MACD
- PRME -0.06
- MBI 0.05
- Stochastic Oscillator
- PRME 34.25
- MBI 75.66
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.